Consistent with this hypothesis, levels of T-cell derived EVs in MS patients, specifically CD4+CCR3+ and CD4+CCR5+, are elevated in the CSF of individuals with Gad+ lesions compared to Gad− lesions [40]. This evidence concerns the gene CD4 and myeloid sarcoma.